CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results
SAN MATEO, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) — CARGO Therapeutics, Inc. (Nasdaq:CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today reported business updates and its financial results for the third quarter ended September 30, 2023.
Related news for (CRGX)
- CARGO Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $4.379 in Cash per Share Plus a Contingent Value Right
- 24/7 Market News Snapshot 08 July, 2025 – CARGO Therapeutics, Inc. Common Stock (NASDAQ:CRGX)
- CARGO Therapeutics Provides Corporate Update
- 24/7 Market News Snapshot 18 March, 2025 – CARGO Therapeutics, Inc. Common Stock (NASDAQ:CRGX)
- CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options